Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 3410135, 8 pages
https://doi.org/10.1155/2018/3410135
Research Article

Adiponectin, Omentin, Ghrelin, and Visfatin Levels in Obese Patients with Severe Obstructive Sleep Apnea

1Department of Respiratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan Street, Dongcheng District, Beijing 100730, China
2Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, The Translational Medicine Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan Street, Dongcheng District, Beijing 100730, China

Correspondence should be addressed to Rong Huang; moc.361@2120gnorgnauh

Received 31 January 2018; Revised 29 May 2018; Accepted 2 July 2018; Published 29 July 2018

Academic Editor: Nikolaos G. Koulouris

Copyright © 2018 Dong-mei Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. E. Peppard, T. Young, J. H. Barnet, M. Palta, E. W. Hagen, and K. M. Hla, “Increased prevalence of sleep-disordered breathing in adults,” American Journal of Epidemiology, vol. 177, no. 9, pp. 1006–1014, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Young, E. Shahar, F. J. Nieto et al., “Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study,” JAMA Internal Medicine, vol. 162, no. 8, pp. 893–900, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Pan and A. J. Kastin, “Leptin: a biomarker for sleep disorders?” Sleep Medicine Reviews, vol. 18, no. 3, pp. 283–290, 2014. View at Publisher · View at Google Scholar
  4. X. L. Zhang, K. S. Yin, H. Mao, H. Wang, and Y. Yang, “Serum adiponectin level in patients with obstructive sleep apnea hypopnea syndrome,” Chinese Medical Journal, vol. 117, pp. 1603–1606, 2004. View at Google Scholar
  5. R. Wolk, A. Svatikova, C. A. Nelson et al., “Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea,” Obesity Research, vol. 13, no. 1, pp. 186–190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. O. K. Kurt, M. Tosun, A. Alcelik, B. Yilmaz, and F. Talay, “Serum omentin levels in patients with obstructive sleep apnea,” Sleep and Breathing, vol. 18, no. 2, pp. 391–395, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Trakada, P. Steiropoulos, E. Nena et al., “Plasma visfatin levels in severe obstructive sleep apnea - Hypopnea syndrome,” Sleep and Breathing, vol. 13, no. 4, pp. 349–355, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Tschöp, C. Weyer, P. A. Tataranni, V. Devanarayan, E. Ravussin, and M. L. Heiman, “Circulating ghrelin levels are decreased in human obesity,” Diabetes, vol. 50, no. 4, pp. 707–709, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Y. Liu, H. M. Yue, J. B. Zhang, J. Y. Pu, and Q. Yu, “Effects of plasma ghrelin, obestatin, and ghrelin/obestatin ratio on blood pressure circadian rhythms in patients with obstructive sleep apnea syndrome,” Chinese Medical Journal, vol. 127, no. 5, pp. 850–855, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Richard, R. B. Berry, E. Charlene, and E. Gamaldo, “The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications,” verson 2.0. American Academy of Sleep Medicine, 2012.
  11. B. K. Tan, R. Adya, and H. S. Randeva, “Omentin: a novel link between inflammation, diabesity, and cardiovascular disease,” Trends in Cardiovascular Medicine, vol. 20, no. 5, pp. 143–148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Shibata, N. Ouchi, R. Takahashi et al., “Omentin as a novel biomarker of metabolic risk factors,” Diabetology & Metabolic Syndrome, vol. 4, no. 1, article 37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Zirlik, K. M. Hildner, A. Targosz et al., “Melatonin and omentin: influence factors in the obstructive sleep apnoea syndrome?” Journal of Physiology and Pharmacology, vol. 64, pp. 353–360, 2013. View at Google Scholar
  14. Q. Wang, X. Feng, C. Zhou, P. Li, and J. Kang, “Decreased levels of serum omentin-1 in patients with obstructive sleep apnoea syndrome,” Annals of Clinical Biochemistry, vol. 50, no. 3, pp. 230–235, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Uygur, H. Tanrıverdi, M. Can et al., “Association between continuous positive airway pressure and circulating omentin levels in patients with obstructive sleep apnoea,” Sleep and Breathing, vol. 20, no. 3, pp. 939–945, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. B. K. Tan, R. Adya, S. Farhatullah et al., “Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome. Ex vivo in vivo regulation of omentin-1 by insulin and glucose,” Diabetes, vol. 57, no. 4, pp. 801–808, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. C. M. De Souza Batista, R.-Z. Yang, M.-J. Lee et al., “Omentin plasma levels and gene expression are decreased in obesity,” Diabetes, vol. 56, no. 6, pp. 1655–1661, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Herder, B. W. C. Bongaerts, D. M. Ouwens et al., “Low serum omentin levels in the elderly population with Type 2 diabetes and polyneuropathy,” Diabetic Medicine, vol. 32, no. 11, pp. 1479–1483, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Herder, D. M. Ouwens, M. Carstensen et al., “Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 Study,” European Journal of Endocrinology, vol. 172, no. 4, pp. 423–432, 2015. View at Publisher · View at Google Scholar
  20. W. H. Feng, X. W. Yuan, G. Y. Tong et al., “Correlated increase of omentin-1 and adiponectin by exenatide, avandamet and dietary change in diet-induced obese rats,” Folia Biologica, vol. 59, pp. 217–224, 2013. View at Google Scholar
  21. W. T. McNicholas and M. R. Bonsigore, “Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities,” European Respiratory Journal, vol. 29, pp. 156–178, 2007. View at Google Scholar
  22. J. M. Moreno-Navarrete, F. Ortega, A. Castro, M. Sabater, W. Ricart, and J. M. Fernández-Real, “Circulating omentin as a novel biomarker of endothelial dysfunction,” Obesity, vol. 19, no. 8, pp. 1552–1559, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. H. J. Yoo, S. Y. Hwang, H. C. Hong et al., “Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes,” Cardiovascular Diabetology, vol. 10, article 103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Shibata, N. Ouchi, R. Kikuchi et al., “Circulating omentin is associated with coronary artery disease in men,” Atherosclerosis, vol. 219, no. 2, pp. 811–814, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Maruyama, R. Shibata, R. Kikuchi et al., “Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism,” The Journal of Biological Chemistry, vol. 287, no. 1, pp. 408–417, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. B. D. Kent, L. Grote, S. Ryan et al., “Diabetes mellitus prevalence and control in sleep-disordered breathing: The European Sleep Apnea Cohort (ESADA) study,” CHEST, vol. 146, no. 4, pp. 982–990, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. N. M. Punjabi, E. Shahar, S. Redline, D. J. Gottlieb, R. Givelber, and H. E. Resnick, “Sleep-disordered breathing, glucose intolerance, and insulin resistance: the sleep heart health study,” American Journal of Epidemiology, vol. 160, no. 6, pp. 521–530, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. K. J. Reichmuth, D. Austin, J. B. Skatrud, and T. Young, “Association of sleep apnea and type II diabetes: a population-based study,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 12, pp. 1590–1595, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. S. L. Appleton, A. Vakulin, R. D. McEvoy et al., “Nocturnal hypoxemia and severe obstructive sleep apnea are associated with incident type 2 diabetes in a population cohort of men,” Journal of Clinical Sleep Medicine, vol. 11, no. 6, pp. 609–614, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. R. S. Aronsohn, H. Whitmore, E. Van Cauter, and E. Tasali, “Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 5, pp. 507–513, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. Q. Zhang, L. Zhu, M. Zheng et al., “Changes of serum omentin-1 levels in normal subjects, type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults,” Annales d'Endocrinologie, vol. 75, no. 3, pp. 171–175, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. H.-Y. Yang, Y. Ma, X.-H. Lu et al., “The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome,” Annales d'Endocrinologie, vol. 76, no. 5, pp. 620–627, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. H.-Y. Pan, L. Guo, and Q. Li, “Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes,” Diabetes Research and Clinical Practice, vol. 88, no. 1, pp. 29–33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Lis, L. Pilarski, and P. Bogdański, “Omentin - a newly-discovered adipocytokine in insulin resistance pathogenesis,” Polski Merkuriusz Lekarski, vol. 39, pp. 56–60, 2015. View at Google Scholar
  35. S. Al Mutairi, O. A. Mojiminiyi, A. Al Alawi, T. Al Rammah, and N. Abdella, “Study of leptin and adiponectin as disease markers in subjects with obstructive sleep apnea,” Disease Markers, vol. 2014, Article ID 706314, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa, “Ghrelin is a growth-hormone-releasing acylated peptide from stomach,” Nature, vol. 402, no. 6762, pp. 656–660, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. I. A. Harsch, P. C. Konturek, and C. Koebnick, “Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment,” European Respiratory Journal, vol. 22, no. 2, pp. 251–257, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. C. T. Ulukavak, O. Kokturk, N. Bukan, and A. Bilgihan, “Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome,” Respiration, vol. 72, pp. 395–401, 2005. View at Google Scholar
  39. A. Fukuhara, M. Matsuda, and M. Nishizawa, “Visfatin: a protein secreted by visceral fat that mimics the effects of insulin,” Science, vol. 307, pp. 426–430, 2005. View at Google Scholar
  40. M. Kiskac, M. Zorlu, and M. E. Akkoyunlu, “Vaspin and lipocalin-2 levels in severe obsructive sleep apnea,” Journal of Thoracic Disease, vol. 6, no. 6, pp. 720–725, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. A. L. Hayes, F. Xu, D. Babineau, and S. R. Patel, “Sleep duration and circulating adipokine levels,” SLEEP, vol. 34, no. 2, pp. 147–152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. S. S. S. Ng, E. K. H. Liu, R. C. W. Ma et al., “Effects of CPAP therapy on visceral fat thickness, carotid intima-media thickness and adipokines in patients with obstructive sleep apnoea,” Respirology, vol. 22, no. 4, pp. 786–792, 2017. View at Publisher · View at Google Scholar · View at Scopus
  43. A. M. Li, C. Ng, S. K. Ng et al., “Adipokines in children with obstructive sleep apnea and the effects of treatment,” CHEST, vol. 137, no. 3, pp. 529–535, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. G. Eun, M. G. Kim, K. H. Kwon, S. Y. Shin, J. S. Cho, and S. W. Kim, “Short-term effect of multilevel surgery on adipokines and pro-inflammatory cytokines in patients with obstructive sleep apnea,” Acta Oto-Laryngologica, vol. 130, no. 12, pp. 1394–1398, 2010. View at Publisher · View at Google Scholar · View at Scopus